- Home
- IMMP vs LE Comparison
IMMP vs LE Comparison
Compare IMMP & LE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- LE
- Stock Information
- Founded
- IMMP 1987
- LE 1963
- Country
- IMMP Australia
- LE United States
- Employees
- IMMP N/A
- LE N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- LE Clothing/Shoe/Accessory Stores
- Sector
- IMMP Health Care
- LE Consumer Discretionary
- Exchange
- IMMP Nasdaq
- LE Nasdaq
- Market Cap
- IMMP 251.8M
- LE 280.4M
- IPO Year
- IMMP N/A
- LE N/A
- Fundamental
- Price
- IMMP $1.57
- LE $10.05
- Analyst Decision
- IMMP Buy
- LE Strong Buy
- Analyst Count
- IMMP 1
- LE 1
- Target Price
- IMMP $7.00
- LE $20.00
- AVG Volume (30 Days)
- IMMP 111.5K
- LE 670.3K
- Earning Date
- IMMP 02-27-2025
- LE 06-05-2025
- Dividend Yield
- IMMP N/A
- LE N/A
- EPS Growth
- IMMP N/A
- LE N/A
- EPS
- IMMP N/A
- LE 0.14
- Revenue
- IMMP $3,019,249.00
- LE $1,338,672,000.00
- Revenue This Year
- IMMP $50.37
- LE $3.31
- Revenue Next Year
- IMMP N/A
- LE $2.34
- P/E Ratio
- IMMP N/A
- LE $74.64
- Revenue Growth
- IMMP 24.11
- LE N/A
- 52 Week Low
- IMMP $1.32
- LE $7.65
- 52 Week High
- IMMP $2.80
- LE $19.88
- Technical
- Relative Strength Index (RSI)
- IMMP 36.75
- LE 59.43
- Support Level
- IMMP $1.51
- LE $8.98
- Resistance Level
- IMMP $1.63
- LE $10.49
- Average True Range (ATR)
- IMMP 0.07
- LE 0.84
- MACD
- IMMP -0.03
- LE 0.15
- Stochastic Oscillator
- IMMP 14.34
- LE 84.33
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically operates in USA, Europe, Asia, it derives a majority of its revenue from the United States.